Cancer Research Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 3653-3657, September 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chu, C.
Right arrow Articles by Magee, P. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chu, C.
Right arrow Articles by Magee, P. N.

Metabolic Fate of Nitrosoproline in the Rat1

Cecilia Chu and Peter N. Magee2

Fels Research Institute [C. C., P. N. M.] and Department of Pathology [P. N. M.], Temple University School of Medicine, Philadelphia, Pennsylvania 19140

The metabolism of [U14C]nitrosoproline and [carboxyl-14C]nitrosoproline was studied in the rat. In most experiments, less than 1% of the administered radioactivity appeared as radioactive CO2 in the expired air, and urinary excretion of radioactivity was rapid and almost complete as the unchanged compound, which was the only radioactive component detected in the urine. The absence of any radioactive urinary components corresponding to proline or its metabolites indicated that no detectable metabolic denitrosation had occurred. Studies of the disappearance of nitrosoproline from the circulating plasma indicated an apparent volume of distribution of 52% of the total body weight, suggesting some penetration by the compound into the intracellular space. There was no significantly detectable covalent binding of radioactivity from the labeled nitrosoproline to DNA or RNA of the liver and only an extremely low level of binding to liver protein. Taken with the reported noncarcinogenicity of nitrosoproline in rodents, the above findings suggest that proline may be a suitable nitrosatable substrate for use in tests of endogenous nitrosation reactions in animals and human subjects.

1 This research was supported by Grants CA 12227 and CA 23451 from the National Cancer Institute, NIH, and by the Samuel S. Fels Fund of Philadelphia.

2 To whom requests for reprints should be addressed.

Received 3/31/81. Accepted 6/17/81.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.